These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2092632)

  • 1. [Experimental study on chemotherapeutic efficacy, acute toxic action and nephrotoxicity of combinations of eremomycin with tobramycin].
    Shepelevtseva NG; Vinogradova IV; Shevniuk LA
    Antibiot Khimioter; 1990 Nov; 35(11):21-4. PubMed ID: 2092632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of the activity of a new glycopeptide antibiotic eremomycin combined with tobramycin against Staphylococci in vitro].
    Iakushkina IV; Malkova IV; Prozorova IN
    Antibiot Khimioter; 1988 May; 33(5):342-5. PubMed ID: 3415389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Eremomycin--a new antibiotic of the polycyclic glycopeptide group].
    Gauze GF; Brazhnikova MG; Lomakina NN; Gol'dberg LE; Laĭko AV
    Antibiot Khimioter; 1989 May; 34(5):348-52. PubMed ID: 2742419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental study of antibacterial activity, therapeutic effectiveness and toxic properties of the combination of tobramycin and carbenicillin].
    Vinogradova IV; Filippos'iants ST; Shevniuk LA
    Antibiot Khimioter; 1989 May; 34(5):382-6. PubMed ID: 2500902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preclinical toxicological study of the new antibiotic eremomycin. Its acute toxicity for laboratory animals].
    Gol'dberg LE; Stepanova ES; Vertogradova TP; Shevniuk LA; Shepelevtseva NG
    Antibiot Med Biotekhnol; 1987 Dec; 32(12):910-5. PubMed ID: 2830839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental study of the antibacterial activity and chemotherapeutic efficacy of the novel glycopeptide eremomycin].
    Malikova IV
    Antibiot Khimioter; 1989 Jan; 34(1):52-6. PubMed ID: 2543344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of daptomycin on staphylococcal abscesses and experimental tobramycin nephrotoxicity.
    Wood CA; Finkbeiner HC; Kohlhepp SJ; Kohnen PW; Gilbert DN
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1280-5. PubMed ID: 2552905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental study of the toxic effect of combinations of tobramycin and carbenicillin].
    Iakushkina IV; Filippos'iants ST; Shevniuk LA
    Antibiotiki; 1984 May; 29(5):361-5. PubMed ID: 6742807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrotoxicity of aminoglycosides and cephalosporins in combination.
    Rankin GO; Sutherland CH
    Adverse Drug React Acute Poisoning Rev; 1989; 8(2):73-88. PubMed ID: 2672726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic combinations in the treatment of experimental Staphylococcus aureus infection.
    Steigbigel RT; Greenman RL; Remington JS
    J Infect Dis; 1975 Mar; 131(3):245-51. PubMed ID: 1127254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of 2-methyl-4-amino-6-hydroxypyrimidine on the effectiveness of antibiotic therapy in experimental staphylococcal infection in the context of immunosuppression].
    Ismagilova AF; Zarudiĭ FS; Davydova VA
    Antibiot Khimioter; 1996 Mar; 41(3):29-31. PubMed ID: 8967799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness of the combined use of tobramycin with carbenicillin or cephalosporins in experimental infection in mice caused by Providencia stuartii].
    Shapovalova SP; Malkova IV; Iakushkina IV
    Antibiotiki; 1982 Feb; 27(2):130-3. PubMed ID: 7065647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental Pseudomonas aeruginosa sepsis: absence of synergy between ticarcillin and tobramycin.
    Chusid MJ; Davis SD; Sarff LD
    J Lab Clin Med; 1983 Mar; 101(3):441-9. PubMed ID: 6402553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preclinical toxicological study of the new antibiotic eremomycin. Chronic toxicity and effect on intrauterine development of rats].
    Shepelevtseva NG; Gol'dberg LE; Vertogradova TP; Shevniuk LA; Stepanova ES
    Antibiot Khimioter; 1988 Apr; 33(4):280-6. PubMed ID: 3389957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro synergy of cefamandole-tobramycin combinations.
    Valenti AJ; Siniscalchi AJ; Andriole VT
    Yale J Biol Med; 1977; 50(2):177-82. PubMed ID: 331694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teicoplanin: renal tolerance and pharmacokinetics in rats.
    Marre R; Schulz E; Graefe H; Sack K
    J Antimicrob Chemother; 1987 Nov; 20(5):697-704. PubMed ID: 2962975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cephalothin plus an aminoglycoside is more nephrotoxic than methicillin plus an aminoglycoside.
    Wade JC; Smith CR; Petty BG; Lipsky JJ; Conrad G; Ellner J; Lietman PS
    Lancet; 1978 Sep; 2(8090):604-6. PubMed ID: 80528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tobramycin--clinical pharmacology and chemotherapy].
    Periti P
    J Chemother; 1996 Jan; 8 Suppl 1():3-30. PubMed ID: 8948764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methicillin-resistant Staphylococcus aureus osteomyelitis.
    Sheftel TG; Mader JT; Pennick JJ; Cierny G
    Clin Orthop Relat Res; 1985 Sep; (198):231-9. PubMed ID: 4028555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapeutic effectiveness of antibiotics in combination with papain in experimental septicemia].
    Baskanchiladze GSh; Khurtsilava LA; Gelovani IA; Asatiani MV; Rossinskii VI
    Antibiotiki; 1984 Jan; 29(1):33-5. PubMed ID: 6696400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.